Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-25T05:08:54.276Z Has data issue: false hasContentIssue false
  • English
  • Français

Trial of a New Phenothiazine in Chronic Schizophrenia

Published online by Cambridge University Press:  08 February 2018

J. W. Garry  and
E. J. Hill
J. W. Garry
Affiliation:
St. Audry's Hospital, Melton, Woodbridge, Suffolk
E. J. Hill
Affiliation:
St. Clement's Hospital, Foxhall Road, Ipswich, Suffolk
Get access Rights & Permissions [Opens in a new window]

Extract

SKF 7261 is a low dosage phenothiazine derivative belonging to the piperazine group, other members of which include trifluoperazine (“Stelazine”), prochlorperazine (“Stemetil”) and perphenazine (“Fentazin”, “Trilafon”).

Type
Therapy
Information
Journal of Mental Science , Volume 108 , Issue 455 , July 1962 , pp. 521 - 524
Copyright
Copyright © Royal College of Psychiatrists, 1962 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Smith Kline & French Laboratories, Pharmacology Department, Philadelphia. Unpublished information.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.